Related Experiment Video
Updated: May 5, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Complications of diabetes therapy
Sarah D Corathers1, Shawn Peavie, Marzieh Salehi
1Division of Endocrinology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 7012, Cincinnati, OH 45229, USA; Division of Endocrinology, University of Cincinnati Medical Center, 260 Stetson, Suite 4200, Cincinnati, OH 45229, USA.
Abstract:
Current strategies for the treatment of type 2 diabetes mellitus promote individualized plans to achieve target glucose levels on a patient-by-patient basis while minimizing treatment related risks. Maintaining glycemic control over time is a significant challenge because of the progressive nature of diabetes as a result of declining β-cell function. This article identifies complications of non-insulin treatments for diabetes. The major classes of medications are reviewed with special focus on target population, mechanism of action, effect on weight, cardiovascular outcomes and additional class-specific side effects including effects on bone. Effects on β-cell function are also highlighted.
Insights
Managing type 2 diabetes requires individualized plans to control glucose and minimize risks. This review details non-insulin medication complications, focusing on side effects and effects on beta-cell function.
Area of Science:
- Endocrinology
- Pharmacology
Background:
- Type 2 diabetes mellitus (T2DM) management focuses on individualized glycemic control.
- Progressive beta-cell dysfunction presents a significant challenge to long-term glycemic control.
- Minimizing treatment-related risks is a key aspect of current T2DM strategies.
Purpose of the Study:
- To identify and review complications associated with non-insulin treatments for T2DM.
- To provide a comprehensive overview of major non-insulin medication classes.
- To highlight effects on beta-cell function and other class-specific side effects.
Main Methods:
- Review of major classes of non-insulin antidiabetic medications.
- Focus on target populations, mechanisms of action, and weight effects.
- Analysis of cardiovascular outcomes and additional class-specific side effects, including bone effects.
Main Results:
- Non-insulin T2DM treatments present various complications and side effects.
- Medication classes differ in their impact on weight, cardiovascular health, and bone.
- Effects on beta-cell function vary among different treatment classes.
Conclusions:
- Understanding non-insulin treatment complications is crucial for individualized T2DM care.
- Class-specific side effects, including impact on bone and cardiovascular outcomes, require careful consideration.
- The progressive nature of T2DM necessitates ongoing evaluation of treatment efficacy and safety, including effects on beta-cell reserve.
Related Concept Videos
Complications of Diabetes Mellitus
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetic Retinopathy
Type I Diabetes III: Clinical Manifestations

